<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:57:06Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18624" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18624</identifier><datestamp>2026-10-18T20:56:40Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Everolimus-Induced Oral Mucositis Can be Prevented by Hippophae Rhamnoides Extract in Rats</dc:title><dc:creator>gezer, arzu</dc:creator><dc:creator>Cil, Ibrahim</dc:creator><dc:creator>Suleyman, Bahadir</dc:creator><dc:creator>Ozcicek, Fatih</dc:creator><dc:creator>Semiz, Huseyin Salih</dc:creator><dc:creator>Akagunduz, Baran</dc:creator><dc:creator>OZER, MUHAMMET</dc:creator><dc:creator>Demircan, Nazım Can</dc:creator><dc:creator>Aktas, Mehmet</dc:creator><dc:creator>Suleyman, Halis</dc:creator><dc:subject>Tıbbi Araştırmalar Deneysel</dc:subject><dc:subject>Dermatoloji</dc:subject><dc:subject>Biyoteknoloji ve Uygulamalı Mikrobiyoloji</dc:subject><dc:description>Objectives: Oral mucositis is a significant toxicity related to the mammalian target of rapamycin inhibitor everolimus. Oxidative stress and pro-inflammatory cytokines, which contribute to treatment-related mucositis, can betargeted with Hippophae rhamnoides extract (HRE). Herein, we assessed the effects of HRE on everolimus-inducedmucositis in rats.Methods: Eighteen rats were equally divided into healthy, everolimus, and everolimus plus HRE groups. Malondialdehyde (MDA) and total glutathione (tGSH) levels along with interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha(TNF-α) gene expression levels were measured in the tongue and buccal mucosa tissues of all groups, histopathologicalchanges were also evaluated. We tested the significance of variations with one-way variance analysis. We also analyzedthe differences between groups with Kruskal–Wallis test and Mann–Whitney U-test.Results: HRE significantly decreased MDA and increased tGSH levels and reduced IL-1β and TNF-α gene expression inboth tissues administered everolimus (p&lt;0.001 for each). Histological examination revealed that HRE improved epithelial formation and keratinization, disrupted by everolimus, and alleviated everolimus-related mononuclear cell infiltration (p&lt;0.05 for each).Conclusion: In light of these results, HRE may be a promising agent to manage oral mucositis caused by everolimus,given the lack of effective therapeutic options for this type of adverse event.</dc:description><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/18624</dc:identifier><dc:identifier>https://doi.org/10.14744/ejmi.2021.60963</dc:identifier><dc:language>en</dc:language><dc:relation>Eurasian Journal of Medical Investigation</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18624</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>